Report Id: SEOVM519
Oral vaccine Market Size By Type (Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine), By Application (Public health care units, Private health care units), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2022-2027
The global oral vaccine market is expected to be around US$ 61 Billion by 2027 at a CAGR of 7% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
Study period:
Fastest Growing Market:
2022-2027
APAC
Base Year:
Largest Market:
2021
North America
CAGR:
7
REPORT DESCRIPTION
The global oral vaccine market is expected to be around US$ 61 Billion by 2027 at a CAGR of 7% in the given forecast period.
Oral vaccines are safe and simple to administer and convenient for all ages. They have been successfully developed to safeguard from several infectious diseases uninheritable through oral transmission. Oral delivery of vaccines represents the foremost enticing mode of administration over other routes of delivery because of the actual fact that the oral vaccination is noninvasive, safe and easy to execute, showing good patient compliance and clinical usefulness.
The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing companies’ initiatives to enhance R&D, Newer and more expensive vaccines are coming into the market faster than ever before.
Market Insights
The global oral vaccine market is segregated on the basis of Type as Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, and Others. Based on Application the global oral vaccine market is segmented in Public health care units and Private health care units.
The global oral vaccine market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The oral vaccine market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, and others are among the major players in the global oral vaccine market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Oral vaccine Market has been segmented as below:
Oral vaccine Market, By Type
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Others
Oral vaccine Market, By Application
- Public health care units
- Private health care units
Oral vaccine Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Oral vaccine Market, By Company
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
The report covers:
- Global oral vaccine market sizes from 2018 to 2027, along with CAGR for 2022-2027
- Market size comparison for 2020 vs 2027 with actual data for 2021, estimates for 2022 and forecast from 2022 to 2027
- Global oral vaccine market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global oral vaccine market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global oral vaccine market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global oral vaccine market share. Major industry players with significant revenue share include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, and others.
Reasons to Buy this Report:
- Gain detailed insights on the oral vaccine industry trends
- Find complete analysis on the market status
- Identify the oral vaccine market opportunities and growth segments
- Analyze competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Global Water Testing & Analysis Market
Remote Sensing Technology Market
Global Flexible Heaters Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. Oral vaccine Market, By Type
5.1 Introduction
5.2 Rotavirus Vaccine
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Cholera Vaccine
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Oral Polio Vaccine
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Others
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Oral vaccine Market, By Application
6.1 Introduction
6.2 Public health care units
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Private health care units
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Oral vaccine Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America oral vaccine, By Type
7.2.2 North America oral vaccine, By Application
7.3 Europe
7.3.1 Europe oral vaccine, By Type
7.3.2 Europe oral vaccine, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific oral vaccine, By Type
7.4.2 Asia-Pacific oral vaccine, By Application
7.5 Rest of the World
7.5.1 Rest of the World oral vaccine, By Type
7.5.2 Rest of the World oral vaccine, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Merck
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 GSK
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Sanofi
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Lanzhou Institute
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Serum Institute
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Valneva
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Shanghai United Cell
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Bibcol
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 PaxVax
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Vabiotech
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Oral vaccine Market has been segmented as below:
Oral vaccine Market, By Type
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Others
Oral vaccine Market, By Application
- Public health care units
- Private health care units
Oral vaccine Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Oral vaccine Market, By Company
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of oral vaccine market?
The market is expected to grow at a CAGR of 7% during the study period (2022-2027)
How big is the oral vaccine market value?
The global oral vaccine market is expected to be around US$ 53.5 Billion by 2025
What is the segment’s covered for the oral vaccine market?
The segment included in oral vaccine market is Type, Application, Company and region.
Who are the major key vendors in the oral vaccine market?
Some key players operating in the oral vaccine market include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech,
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE